메뉴 건너뛰기




Volumn 18, Issue 1, 2012, Pages 4-10

Bacterial proteins: A new class of cancer therapeutics

Author keywords

Anticancer drugs; Azurin; Bacterial proteins; Cancer eradication; Cancer prevention; Human clinical trials

Indexed keywords

ANTICANCER DRUG; AZURIN; BACTERIAL PROTEINS; CANCER ERADICATION; CANCER PREVENTION; CLINICAL TRIAL;

EID: 84858984935     PISSN: 14628732     EISSN: 1478565X     Source Type: Journal    
DOI: 10.5912/jcb.466     Document Type: Review
Times cited : (7)

References (13)
  • 1
    • 25144449123 scopus 로고    scopus 로고
    • Internalization of bacterial redox protein azurin in mammalian cells: Entry domain and specificity
    • DOI 10.1111/j.1462-5822.2005.00567.x
    • Yamada, T. et al (2005) Internalization of bacterial redox protein azurin in mammalian cells: entry domain and specificity. Cellular Microbiology 7: 1418-1431. (Pubitemid 41335246)
    • (2005) Cellular Microbiology , vol.7 , Issue.10 , pp. 1418-1431
    • Yamada, T.1    Fialho, A.M.2    Punj, V.3    Bratescu, L.4    Das, G.T.K.5    Chakrabarty, A.M.6
  • 2
    • 84886823398 scopus 로고    scopus 로고
    • Promiscuous anticancer drugs from pathogenic bacteria: Rational versus intelligent drug design
    • A.M. Fialho & A.M. Chakrabarty, Eds. John Wiley & Sons, Hoboken, NJ
    • Fialho, A.M. and Chakrabarty, A.M. (2010) Promiscuous anticancer drugs from pathogenic bacteria: rational versus intelligent drug design. In Emerging Cancer Therapy: Microbial Approaches and Biotechnological Tools. A.M. Fialho & A.M. Chakrabarty, Eds. P. 181-198. John Wiley & Sons, Hoboken, NJ.
    • (2010) Emerging Cancer Therapy: Microbial Approaches and Biotechnological Tools , pp. 181-198
    • Fialho, A.M.1    Chakrabarty, A.M.2
  • 4
    • 77957588116 scopus 로고    scopus 로고
    • Compositions and methods to control angiogenesis with cupredoxins
    • US Patent 7,556,810 issued on July 07, 2009
    • Mehta, R.R. et al (2009) Compositions and methods to control angiogenesis with cupredoxins. US Patent 7,556,810 issued on July 07, 2009.
    • (2009)
    • Mehta, R.R.1
  • 6
    • 79959999423 scopus 로고    scopus 로고
    • Compositions and methods to prevent cancer with cupredoxins
    • US Patent 7,618,939 issued on November 17, 2009
    • Das Gupta, T.K and Chakrabarty, A.M. (2009) Compositions and methods to prevent cancer with cupredoxins. US Patent 7,618,939 issued on November 17, 2009.
    • (2009)
    • Das Gupta, T.K.1    Chakrabarty, A.M.2
  • 7
    • 34249950368 scopus 로고    scopus 로고
    • Beyond host-pathogen interactions: microbial defense strategy in the host environment
    • DOI 10.1016/j.copbio.2007.04.001, PII S095816690700050X, Energy biotechnology / Environmental biotechnology
    • Fialho, A.M. et al (2007) Beyond host-pathogen interactions: microbial defense strategy in the host environment. Current Opinion in Biotechnology 18: 279-286. (Pubitemid 46880281)
    • (2007) Current Opinion in Biotechnology , vol.18 , Issue.3 , pp. 279-286
    • Fialho, A.M.1    Stevens, F.J.2    Das, G.T.K.3    Chakrabarty, A.M.4
  • 8
    • 33846004207 scopus 로고    scopus 로고
    • Bacterial proteins and CpG-rich extrachromosomal DNA in potential cancer therapy
    • DOI 10.1016/j.plasmid.2006.11.001, PII S0147619X06001107
    • Mahfouz, M. et al. (2007) Bacterial proteins and CpG-rich extrachromosomal DNA in potential cancer therapy. Plasmid 57: 4-17. (Pubitemid 46054159)
    • (2007) Plasmid , vol.57 , Issue.1 , pp. 4-17
    • Mahfouz, M.1    Hashimoto, W.2    Das, G.T.K.3    Chakrabarty, A.M.4
  • 9
    • 79960927023 scopus 로고    scopus 로고
    • Preclinical pharmacokinetics, metabolism, and toxicity of azurin-p28 (NSC745104) a peptide inhibitor of p53 ubiquitination
    • in press
    • Jia, L. et al (2010) Preclinical pharmacokinetics, metabolism, and toxicity of azurin-p28 (NSC745104) a peptide inhibitor of p53 ubiquitination. Cancer Chemotherapy & Pharmacology, in press.
    • (2010) Cancer Chemotherapy & Pharmacology
    • Jia, L.1
  • 10
    • 33847043161 scopus 로고    scopus 로고
    • Cupredoxin-cancer interrelationship: Azurin binding with EphB2, interference in EphB2 tyrosine phosphorylation and inhibition of cancer growth
    • Chaudhari, A. et al (2007) Cupredoxin-cancer interrelationship: azurin binding with EphB2, interference in EphB2 tyrosine phosphorylation and inhibition of cancer growth. Biochemistry 46: 1799-1810.
    • (2007) Biochemistry , vol.46 , pp. 1799-1810
    • Chaudhari, A.1
  • 12
    • 84886815296 scopus 로고    scopus 로고
    • The role and importance of intellectual property generation and protection in drug development
    • A.M. Fialho & A.M. Chakrabarty, Eds. John Wiley & Sons, Hoboken, NJ
    • Fialho, A.M. and Chakrabarty, A.M. (2010) The role and importance of intellectual property generation and protection in drug development. In Emerging Cancer Therapy: Microbial Approaches and Biotechnological Tools. A.M. Fialho & A.M. Chakrabarty, Eds. P. 405- 419. John Wiley & Sons, Hoboken, NJ
    • (2010) Emerging Cancer Therapy: Microbial Approaches and Biotechnological Tools , pp. 405-419
    • Fialho, A.M.1    Chakrabarty, A.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.